Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interim analysis: the alpha spending function approach

D L DeMets1, K K Lan

  • 1University of Wisconsin Medical School, Madison 53706-1532.

Statistics in Medicine
|July 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical issues in interpreting clinical trials.

Journal of internal medicine·2004
Same author

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

Controlled clinical trials·2001
Same author

Statistical issues relating to international differences in clinical trials.

American heart journal·2001
Same author

Effect of carvedilol on survival in severe chronic heart failure.

The New England journal of medicine·2001
Same author

The Data and Safety Monitoring Committee: Some final thoughts.

American heart journal·2001
Same author

An overview of group sequential methods in longitudinal clinical trials.

Statistical methods in medical research·2001
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
Same journal

Subgroup Analysis of Interval-censored Failure Time Data With Application to Alzheimer's Disease.

Statistics in medicine·2026
Same journal

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same journal

A Multi-Stage Drop-the-Loser Design With Superiority Boundaries.

Statistics in medicine·2026
Same journal

Interpretable ROI Identification in Brain Image Analysis: Overcoming CNN Black Box Challenges With Kriging-Enhanced Adaptive Sampling.

Statistics in medicine·2026
See all related articles

Interim analyses in clinical trials require careful statistical methods to avoid inflating false positive rates. The alpha spending function provides a flexible approach to control error rates during these repeated tests.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Statistical Methodology

Background:

  • Interim analysis of accumulating data is standard practice in clinical trials for ethical and scientific reasons.
  • Repeatedly analyzing interim data without proper statistical control can inflate false positive error rates.
  • Group sequential methods are a common frequentist approach to manage error rates in interim analyses.

Purpose of the Study:

  • To review the alpha spending function approach for group sequential methods.
  • To detail the applicability of alpha spending functions to various statistical procedures.
  • To provide guidance on controlling Type I error rates in clinical trial interim analyses.

Main Methods:

  • Review of the alpha spending function methodology.

Related Experiment Videos

  • Discussion of its implementation in group sequential trial designs.
  • Exploration of its use with survival and longitudinal data analysis.

    • Main Results:

    • The alpha spending function offers a flexible framework for designing group sequential boundaries.
    • This method effectively controls the overall Type I error rate across multiple interim analyses.
    • The approach is adaptable to diverse statistical procedures commonly used in clinical research.

    Conclusions:

    • The alpha spending function is a valuable tool for robust interim analysis in clinical trials.
    • It allows for flexible trial monitoring while maintaining statistical integrity.
    • Its application extends to complex data types like survival and longitudinal data.